Distinct roles of arginases 1 and 2 in diabetic nephropathy.

about

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

Item

http://www.wikidata.org/entity/Q51033386

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

@en

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

@nl

type

Item

label

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

@en

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

@nl

prefLabel

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

@en

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

@nl

P1476

Distinct roles of arginases 1 and 2 in diabetic nephropathy.

@en

P2093

Alaa S Awad

http://www.w3.org/2001/XMLSchema#string

Hanning You

http://www.w3.org/2001/XMLSchema#string

Jean Vacher

http://www.w3.org/2001/XMLSchema#string

Sidney M Morris

http://www.w3.org/2001/XMLSchema#string

Timothy K Cooper

http://www.w3.org/2001/XMLSchema#string

Ting Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Arginine metabolism: nitric oxide and beyond

Mouse model for human arginase deficiency

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component

Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury

Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency

Asymmetric dimethylarginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells.

Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling.

Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation

P304

F899-F905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPRENAL.00158.2017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

313

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28446459

http://www.w3.org/2001/XMLSchema#string

P932

5668588

http://www.w3.org/2001/XMLSchema#string